RadNet, Inc. (RDNT) · Oct 26, 2026 · Acquisition
OnRad merger signed
RadNet’s acquisition of OnRad adds a large teleradiology platform, but this filing leaves the purchase price, financing and closing timing unclear.
RadNet is expanding beyond its 442-center outpatient imaging network while scaling DeepHealth, its AI and enterprise-imaging platform. OnRad adds a complementary teleradiology operation serving more than 300 customers across 30-plus states, with more than 135 board-certified radiologists and roughly 7,500 daily reads.
The strategic direction is clear: RadNet is buying outsourced radiology capacity and reach. The filing confirms that an Agreement and Plan of Merger was signed on October 26, 2026, with RadNet Management as purchaser and OnRad being merged into a RadNet-controlled structure. 〔0〕 That fits RadNet’s broader push to combine physical imaging operations with digital and remote-reading capabilities, but this document does not disclose the purchase price, financing, expected revenue contribution, or synergies.
The support agreement reduces execution friction but is not the economic announcement. The selling stockholder is barred from transferring the covered securities before closing and agrees to confidentiality, non-solicitation, non-compete and post-closing lock-up provisions. 〔1〕 Those provisions help preserve OnRad’s employees, customer relationships and goodwill during the transition, but they do not establish that the transaction is accretive or attractive at the price RadNet is paying.
The main information gap is valuation and funding. The filing says the restrictive covenants become effective at closing and terminate if the merger agreement is validly terminated before closing. 〔2〕 Without consideration terms or a closing timetable, the market can assess the strategic fit but not the financial trade-off.
Bottom line: This advances RadNet’s teleradiology and end-to-end imaging strategy, but the filing is mostly transaction-support documentation. Its ultimate importance depends on the undisclosed price, funding structure and closing terms that have not yet been provided here.
Merger closing, subject to deal conditions
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!